Members of the Kidney Cancer Association are attending the 2012 Genitourinary Cancers Symposium in San Francisco this week. Our Medical & Scientific Steering Committee meets here and we convened the first meeting of our new Neoadjuvant Group. We are currently studying the formation of a Kidney Cancer Association Clinical Trials Consortium that may address specific unmet needs in research.
We encourage patients and their family members to invest the time necessary to evaluate information from this imporant Symposium that is freely available online from ASCO. If you have specific questions, we’ll gladly refer these queries to medical experts. Generally speaking, it may not be wise for patients to rely on the judgment of those who lack a medical background when interpreting information from this meeting.
Note that Saturday’s (February 4) sessions are dedicated almost exclusively to renal cancers. Many of those making presentations at this year’s Symposium are either members of the Kidney Cancer Association Medical & Scientific Steering Committee or of our Professional Group. We are grateful for the dedication of these individuals for their signficant contributions to kidney cancer research.